Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2
{{output}}
Background: Neutralizing antibodies (nAbs) against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) can play an important role in reducing impacts of the COVID-19 pandemic, complementing ongoing public health efforts ... ...
